nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—GABRB2—GABA A receptor activation—GABRQ—attention deficit hyperactivity disorder	0.0323	0.0453	CbGpPWpGaD
Alprazolam—GABRA5—GABA A receptor activation—GABRQ—attention deficit hyperactivity disorder	0.0314	0.044	CbGpPWpGaD
Alprazolam—GABRA3—GABA A receptor activation—GABRQ—attention deficit hyperactivity disorder	0.0308	0.0432	CbGpPWpGaD
Alprazolam—GABRA2—GABA A receptor activation—GABRQ—attention deficit hyperactivity disorder	0.0303	0.0424	CbGpPWpGaD
Alprazolam—GABRB3—GABA A receptor activation—GABRQ—attention deficit hyperactivity disorder	0.0301	0.0422	CbGpPWpGaD
Alprazolam—GABRG2—GABA A receptor activation—GABRQ—attention deficit hyperactivity disorder	0.0295	0.0414	CbGpPWpGaD
Alprazolam—GABRA1—GABA A receptor activation—GABRQ—attention deficit hyperactivity disorder	0.0258	0.0362	CbGpPWpGaD
Alprazolam—GABRB2—Ligand-gated ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.0198	0.0277	CbGpPWpGaD
Alprazolam—GABRA5—Ligand-gated ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.0192	0.0269	CbGpPWpGaD
Alprazolam—GABRA3—Ligand-gated ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.0189	0.0264	CbGpPWpGaD
Alprazolam—GABRA2—Ligand-gated ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.0185	0.026	CbGpPWpGaD
Alprazolam—GABRB3—Ligand-gated ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.0184	0.0258	CbGpPWpGaD
Alprazolam—GABRG2—Ligand-gated ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.0181	0.0254	CbGpPWpGaD
Alprazolam—GABRA1—Ligand-gated ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.0158	0.0222	CbGpPWpGaD
Alprazolam—GABRA5—forebrain—attention deficit hyperactivity disorder	0.014	0.0599	CbGeAlD
Alprazolam—GABRB2—forebrain—attention deficit hyperactivity disorder	0.0106	0.0454	CbGeAlD
Alprazolam—GABRG2—forebrain—attention deficit hyperactivity disorder	0.0106	0.0454	CbGeAlD
Alprazolam—GABRB2—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.0105	0.0147	CbGpPWpGaD
Alprazolam—GABRA5—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.0102	0.0143	CbGpPWpGaD
Alprazolam—GABRA3—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.01	0.014	CbGpPWpGaD
Alprazolam—GABRA2—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.00984	0.0138	CbGpPWpGaD
Alprazolam—GABRB3—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.00977	0.0137	CbGpPWpGaD
Alprazolam—GABRA2—forebrain—attention deficit hyperactivity disorder	0.00968	0.0415	CbGeAlD
Alprazolam—GABRG2—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.0096	0.0135	CbGpPWpGaD
Alprazolam—GABRA1—forebrain—attention deficit hyperactivity disorder	0.00936	0.0401	CbGeAlD
Alprazolam—GABRA1—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.00839	0.0118	CbGpPWpGaD
Alprazolam—GABRB3—forebrain—attention deficit hyperactivity disorder	0.00814	0.0349	CbGeAlD
Alprazolam—GABRA5—nervous system—attention deficit hyperactivity disorder	0.00758	0.0325	CbGeAlD
Alprazolam—GABRA5—central nervous system—attention deficit hyperactivity disorder	0.0073	0.0313	CbGeAlD
Alprazolam—GABRA3—nervous system—attention deficit hyperactivity disorder	0.00706	0.0303	CbGeAlD
Alprazolam—GABRG2—midbrain—attention deficit hyperactivity disorder	0.007	0.03	CbGeAlD
Alprazolam—GABRB2—midbrain—attention deficit hyperactivity disorder	0.007	0.03	CbGeAlD
Alprazolam—GABRA3—central nervous system—attention deficit hyperactivity disorder	0.0068	0.0291	CbGeAlD
Alprazolam—GABRA1—midbrain—attention deficit hyperactivity disorder	0.00618	0.0265	CbGeAlD
Alprazolam—GABRB2—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00612	0.00858	CbGpPWpGaD
Alprazolam—GABRA5—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00594	0.00833	CbGpPWpGaD
Alprazolam—GABRA3—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00584	0.00818	CbGpPWpGaD
Alprazolam—GABRA5—brain—attention deficit hyperactivity disorder	0.0058	0.0248	CbGeAlD
Alprazolam—GABRB2—nervous system—attention deficit hyperactivity disorder	0.00575	0.0247	CbGeAlD
Alprazolam—GABRG2—nervous system—attention deficit hyperactivity disorder	0.00575	0.0247	CbGeAlD
Alprazolam—GABRA2—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00574	0.00804	CbGpPWpGaD
Alprazolam—GABRB3—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.0057	0.00799	CbGpPWpGaD
Alprazolam—GABRG2—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.0056	0.00784	CbGpPWpGaD
Alprazolam—GABRB2—central nervous system—attention deficit hyperactivity disorder	0.00554	0.0238	CbGeAlD
Alprazolam—GABRG2—central nervous system—attention deficit hyperactivity disorder	0.00554	0.0238	CbGeAlD
Alprazolam—GABRB2—cerebellum—attention deficit hyperactivity disorder	0.00542	0.0232	CbGeAlD
Alprazolam—GABRG2—cerebellum—attention deficit hyperactivity disorder	0.00542	0.0232	CbGeAlD
Alprazolam—GABRA3—brain—attention deficit hyperactivity disorder	0.0054	0.0231	CbGeAlD
Alprazolam—GABRB3—midbrain—attention deficit hyperactivity disorder	0.00538	0.023	CbGeAlD
Alprazolam—Halazepam—GABRQ—attention deficit hyperactivity disorder	0.00526	0.0984	CrCbGaD
Alprazolam—GABRA2—nervous system—attention deficit hyperactivity disorder	0.00526	0.0225	CbGeAlD
Alprazolam—Nitrazepam—GABRQ—attention deficit hyperactivity disorder	0.00523	0.0978	CrCbGaD
Alprazolam—GABRA1—nervous system—attention deficit hyperactivity disorder	0.00508	0.0218	CbGeAlD
Alprazolam—GABRA2—central nervous system—attention deficit hyperactivity disorder	0.00506	0.0217	CbGeAlD
Alprazolam—GABRA2—cerebellum—attention deficit hyperactivity disorder	0.00495	0.0212	CbGeAlD
Alprazolam—GABRA1—central nervous system—attention deficit hyperactivity disorder	0.00489	0.021	CbGeAlD
Alprazolam—GABRA1—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00489	0.00686	CbGpPWpGaD
Alprazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00482	0.00676	CbGpPWpGaD
Alprazolam—GABRA1—cerebellum—attention deficit hyperactivity disorder	0.00478	0.0205	CbGeAlD
Alprazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00469	0.00657	CbGpPWpGaD
Alprazolam—Flurazepam—GABRQ—attention deficit hyperactivity disorder	0.00465	0.0869	CrCbGaD
Alprazolam—Triazolam—GABRQ—attention deficit hyperactivity disorder	0.00464	0.0868	CrCbGaD
Alprazolam—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.00462	0.0198	CbGeAlD
Alprazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.0046	0.00645	CbGpPWpGaD
Alprazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00452	0.00634	CbGpPWpGaD
Alprazolam—Oxazepam—GABRQ—attention deficit hyperactivity disorder	0.0045	0.0842	CrCbGaD
Alprazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00449	0.0063	CbGpPWpGaD
Alprazolam—Temazepam—GABRQ—attention deficit hyperactivity disorder	0.00444	0.0831	CrCbGaD
Alprazolam—GABRB3—nervous system—attention deficit hyperactivity disorder	0.00442	0.0189	CbGeAlD
Alprazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00441	0.00618	CbGpPWpGaD
Alprazolam—GABRB2—brain—attention deficit hyperactivity disorder	0.0044	0.0189	CbGeAlD
Alprazolam—GABRG2—brain—attention deficit hyperactivity disorder	0.0044	0.0189	CbGeAlD
Alprazolam—Midazolam—GABRQ—attention deficit hyperactivity disorder	0.00431	0.0806	CrCbGaD
Alprazolam—GABRB2—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00429	0.00602	CbGpPWpGaD
Alprazolam—GABRB3—central nervous system—attention deficit hyperactivity disorder	0.00425	0.0182	CbGeAlD
Alprazolam—GABRA5—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00417	0.00585	CbGpPWpGaD
Alprazolam—GABRB3—cerebellum—attention deficit hyperactivity disorder	0.00416	0.0178	CbGeAlD
Alprazolam—GABRA3—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00409	0.00574	CbGpPWpGaD
Alprazolam—GABRA2—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00402	0.00564	CbGpPWpGaD
Alprazolam—GABRA2—brain—attention deficit hyperactivity disorder	0.00402	0.0172	CbGeAlD
Alprazolam—GABRB3—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.004	0.0056	CbGpPWpGaD
Alprazolam—GABRG2—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00393	0.0055	CbGpPWpGaD
Alprazolam—GABRA1—brain—attention deficit hyperactivity disorder	0.00388	0.0167	CbGeAlD
Alprazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00386	0.00541	CbGpPWpGaD
Alprazolam—Diazepam—GABRQ—attention deficit hyperactivity disorder	0.00369	0.0691	CrCbGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00363	0.00508	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00352	0.00494	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00346	0.00485	CbGpPWpGaD
Alprazolam—GABRA1—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00343	0.00481	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.0034	0.00477	CbGpPWpGaD
Alprazolam—GABRB3—brain—attention deficit hyperactivity disorder	0.00338	0.0145	CbGeAlD
Alprazolam—GABRB3—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00338	0.00473	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00332	0.00465	CbGpPWpGaD
Alprazolam—Loxapine—DRD5—attention deficit hyperactivity disorder	0.00307	0.0575	CrCbGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.0029	0.00406	CbGpPWpGaD
Alprazolam—Loxapine—ADRA2C—attention deficit hyperactivity disorder	0.0029	0.0542	CrCbGaD
Alprazolam—GABRB2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00278	0.00389	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.0027	0.00378	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00265	0.00372	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.0026	0.00365	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00259	0.00363	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00254	0.00356	CbGpPWpGaD
Alprazolam—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00226	0.0097	CbGeAlD
Alprazolam—GABRA1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00222	0.00311	CbGpPWpGaD
Alprazolam—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00218	0.00934	CbGeAlD
Alprazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00212	0.00298	CbGpPWpGaD
Alprazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00206	0.00289	CbGpPWpGaD
Alprazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00203	0.00284	CbGpPWpGaD
Alprazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00199	0.00279	CbGpPWpGaD
Alprazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00198	0.00277	CbGpPWpGaD
Alprazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00194	0.00272	CbGpPWpGaD
Alprazolam—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00191	0.00267	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00186	0.0026	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00181	0.00254	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.0018	0.00253	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00177	0.00248	CbGpPWpGaD
Alprazolam—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00174	0.00244	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00174	0.00244	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00173	0.00242	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.0017	0.00238	CbGpPWpGaD
Alprazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.0017	0.00238	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.0016	0.00224	CbGpPWpGaD
Alprazolam—Loxapine—DRD4—attention deficit hyperactivity disorder	0.00157	0.0294	CrCbGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00157	0.0022	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00156	0.00218	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00155	0.00217	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00152	0.00213	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00152	0.00213	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.0015	0.0021	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00149	0.00209	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00149	0.00209	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00149	0.00208	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00148	0.00208	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00148	0.00208	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00147	0.00206	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00146	0.00205	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00146	0.00204	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00145	0.00203	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00145	0.00203	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00145	0.00203	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00144	0.00202	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00143	0.00201	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00143	0.002	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00142	0.00199	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00142	0.00198	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0014	0.00196	CbGpPWpGaD
Alprazolam—Loxapine—HTR1B—attention deficit hyperactivity disorder	0.0014	0.0261	CrCbGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00139	0.00195	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00139	0.00195	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00138	0.00194	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00138	0.00194	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00137	0.00192	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00136	0.0019	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00136	0.0019	CbGpPWpGaD
Alprazolam—Loxapine—DRD3—attention deficit hyperactivity disorder	0.00135	0.0254	CrCbGaD
Alprazolam—GABRA2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00133	0.00187	CbGpPWpGaD
Alprazolam—Loxapine—DRD1—attention deficit hyperactivity disorder	0.00133	0.0249	CrCbGaD
Alprazolam—GABRB3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00132	0.00186	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00132	0.00185	CbGpPWpGaD
Alprazolam—GABRB3—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.00131	0.00183	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.0013	0.00182	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00128	0.0018	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00128	0.00179	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00126	0.00177	CbGpPWpGaD
Alprazolam—Loxapine—SLC6A3—attention deficit hyperactivity disorder	0.00126	0.0236	CrCbGaD
Alprazolam—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00126	0.00177	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00125	0.00175	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00124	0.00174	CbGpPWpGaD
Alprazolam—Loxapine—ADRA2A—attention deficit hyperactivity disorder	0.00124	0.0231	CrCbGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00123	0.00173	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00122	0.00171	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00121	0.0017	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00119	0.00167	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00119	0.00167	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00119	0.00166	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00117	0.00164	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00115	0.00161	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00114	0.0016	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00114	0.00159	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00114	0.00159	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00112	0.00158	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00112	0.00157	CbGpPWpGaD
Alprazolam—GABRB2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00112	0.00157	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.0011	0.00155	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00109	0.00153	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00109	0.00153	CbGpPWpGaD
Alprazolam—GABRA5—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00108	0.00152	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00108	0.00152	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00107	0.0015	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00107	0.00149	CbGpPWpGaD
Alprazolam—GABRA3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00107	0.00149	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00106	0.00148	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00106	0.00148	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00105	0.00148	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00105	0.00147	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00105	0.00147	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00105	0.00147	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00104	0.00146	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00104	0.00146	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00103	0.00144	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00102	0.00143	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00101	0.00142	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000985	0.00138	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000978	0.00137	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000967	0.00136	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00095	0.00133	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000944	0.00132	CbGpPWpGaD
Alprazolam—Loxapine—SLC6A4—attention deficit hyperactivity disorder	0.000943	0.0176	CrCbGaD
Alprazolam—Loxapine—DRD2—attention deficit hyperactivity disorder	0.000938	0.0175	CrCbGaD
Alprazolam—CYP3A7—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000933	0.00131	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000927	0.0013	CbGpPWpGaD
Alprazolam—CYP3A7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000926	0.0013	CbGpPWpGaD
Alprazolam—CYP3A7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00092	0.00129	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000909	0.00127	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000899	0.00126	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000893	0.00125	CbGpPWpGaD
Alprazolam—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000888	0.00125	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000888	0.00124	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000862	0.00121	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000856	0.0012	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000837	0.00117	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000831	0.00117	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000822	0.00115	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000816	0.00114	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00081	0.00114	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000808	0.00113	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000803	0.00113	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000802	0.00112	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000797	0.00112	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000788	0.0011	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000783	0.0011	CbGpPWpGaD
Alprazolam—Loxapine—HTR2A—attention deficit hyperactivity disorder	0.000725	0.0136	CrCbGaD
Alprazolam—GABRA1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000689	0.000966	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000684	0.000959	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000674	0.000945	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000669	0.000939	CbGpPWpGaD
Alprazolam—CYP3A5—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000665	0.000932	CbGpPWpGaD
Alprazolam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000586	0.000821	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000545	0.000764	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000529	0.000742	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00052	0.000729	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000511	0.000716	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000507	0.000711	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000498	0.000699	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000475	0.000666	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000472	0.000662	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.00047	0.000659	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000469	0.000657	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000436	0.000611	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000381	0.000535	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000313	0.000439	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000311	0.000436	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000309	0.000433	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000276	0.000387	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000263	0.000369	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000263	0.000369	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000259	0.000363	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000241	0.000338	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00021	0.000295	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.0002	0.000281	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000194	0.000272	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00019	0.000267	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00019	0.000267	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000187	0.000262	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000174	0.000244	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	0.00016	0.000224	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000158	0.000222	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000152	0.000213	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000145	0.000203	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000134	0.000188	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000134	0.000188	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000132	0.000185	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000128	0.00018	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000123	0.000172	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	0.000115	0.000162	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000114	0.000161	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000107	0.00015	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000102	0.000143	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	8.85e-05	0.000124	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.85e-05	0.000124	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	8.7e-05	0.000122	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	8.13e-05	0.000114	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.09e-05	0.000113	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	8.07e-05	0.000113	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	7.83e-05	0.00011	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.07e-05	9.92e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	6.84e-05	9.59e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.73e-05	9.44e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	5.36e-05	7.52e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	5.32e-05	7.46e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	4.94e-05	6.93e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	3.49e-05	4.89e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.3e-05	3.22e-05	CbGpPWpGaD
